"Nebraska Cancer Specialists in Omaha, NE is a regional leader in Community Oncology. The practice consists of medical and hematology, nuclear medicine and radiation oncology physicians, a robust Clinical Trial Research Department and the first dedicated Theranostics Center in the region."

During the past decade, Alegant Health Cancer Center at Bergan Mercy Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 63 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alegant Health Cancer Center at Bergan Mercy Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 55 trials, followed by "NSABP Foundation Inc" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored, "Eastern Cooperative Oncology Group" with 6 trials sponsored and "Radiation Therapy Oncology Group" with 6 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alegant Health Cancer Center at Bergan Mercy Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 83 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Alegant Health Cancer Center at Bergan Mercy Medical Center" are "Breast Cancer" (23 trials), "Lung Cancer" (13 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (11 trials), "Colorectal Cancer" (8 trials) and "Metastatic Cancer" (6 trials). Many other conditions were trialed in "Alegant Health Cancer Center at Bergan Mercy Medical Center" in a lesser frequency.

Most popular intervention types in "Alegant Health Cancer Center at Bergan Mercy Medical Center" are "Drug" (70 trials), "Biological" (27 trials), "Other" (25 trials), "Radiation" (14 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (20 trials), "bevacizumab" (10 trials), "carboplatin" (9 trials), "cetuximab" (7 trials) and "cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Alegant Health Cancer Center at Bergan Mercy Medical Center" are 67 trials for "All" genders, 13 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Alegant Health Cancer Center at Bergan Mercy Medical Center". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 69 completed trials in Alegant Health Cancer Center at Bergan Mercy Medical Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Alegant Health Cancer Center at Bergan Mercy Medical Center, 4 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".